Found: 15
Select item for more details and to access through your institution.
Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Somatostatin, Cortistatin and Their Receptors Exert Antitumor Actions in Androgen-Independent Prostate Cancer Cells: Critical Role of Endogenous Cortistatin.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 21, p. 13003, doi. 10.3390/ijms232113003
- By:
- Publication type:
- Article
Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02153-9
- By:
- Publication type:
- Article
Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Novel Potential Biomarker in Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Clinical & Translational Gastroenterology, 2018, v. 9, n. 10, p. 1, doi. 10.1038/s41424-018-0058-8
- By:
- Publication type:
- Article
Calcitriol-Mediated Hypercalcemia, Somatostatin Receptors Expression and 25-Hydroxyvitamin D<sub>3</sub>-1α- Hydroxylase in GIST Tumors.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Epigenetic and post‐transcriptional regulation of somatostatin receptor subtype 5 (SST<sub>5</sub>) in pituitary and pancreatic neuroendocrine tumors.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 3, p. 764, doi. 10.1002/1878-0261.13107
- By:
- Publication type:
- Article
Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors.
- Published in:
- Endocrine (1355008X), 2018, v. 59, n. 2, p. 426, doi. 10.1007/s12020-017-1482-3
- By:
- Publication type:
- Article
The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities.
- Published in:
- Reviews in Endocrine & Metabolic Disorders, 2023, v. 24, n. 2, p. 267, doi. 10.1007/s11154-022-09771-4
- By:
- Publication type:
- Article
Multilayered heterogeneity as an intrinsic hallmark of neuroendocrine tumors.
- Published in:
- Reviews in Endocrine & Metabolic Disorders, 2018, v. 19, n. 2, p. 179, doi. 10.1007/s11154-018-9465-0
- By:
- Publication type:
- Article
Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02858-z
- By:
- Publication type:
- Article
Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate Cancer.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 9, p. 1400, doi. 10.3390/jcm8091400
- By:
- Publication type:
- Article
Type 2 Diabetes in Neuroendocrine Tumors: Are Biguanides and Statins Part of the Solution?
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2019, v. 104, n. 1, p. 57, doi. 10.1210/jc.2018-01455
- By:
- Publication type:
- Article
Type 2 Diabetes in Neuroendocrine Tumors: Are Biguanides and Statins Part of the Solution?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer.
- Published in:
- Prostate, 2017, v. 77, n. 15, p. 1499, doi. 10.1002/pros.23426
- By:
- Publication type:
- Article
Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04754-8
- By:
- Publication type:
- Article